In this video, Jorge Cortes, MD, Augusta University, Augusta, GA, briefly discusses upcoming trials of interest in chronic myeloid leukemia (CML), highlighting trials evaluating asciminib in the frontline setting, as well as trials evaluating second-line treatment options for patients. Dr Cortes also comments on the importance of exploring different approaches to improve treatment-free remission (TFR) rates in patients. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.